2016
DOI: 10.1002/14651858.cd012341
|View full text |Cite
|
Sign up to set email alerts
|

Plasma transfusion to prevent intraventricular haemorrhage in very preterm infants

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 35 publications
0
2
0
Order By: Relevance
“…In many instances, FFP might be administered just to correct "prolonged" values in coagulation tests that might actually be developmentally appropriate. A large proportion of FFP transfusions in these infants cannot be easily justified based on risk or prior confirmed hemorrhage 5,6 To optimize FFP transfusions in neonates, we need better understanding of the developmental changes in various physiological markers of hemostasis and the interpretation of coagulation tests to detect coagulopathy. The levels of most coagulation proteins in premature infants change with gestational development , resulting in wide ranges of standard coagulation screening tests such as the prothrombin time (PT) and activated plasma thromboplastin time (APTT, Fig.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…In many instances, FFP might be administered just to correct "prolonged" values in coagulation tests that might actually be developmentally appropriate. A large proportion of FFP transfusions in these infants cannot be easily justified based on risk or prior confirmed hemorrhage 5,6 To optimize FFP transfusions in neonates, we need better understanding of the developmental changes in various physiological markers of hemostasis and the interpretation of coagulation tests to detect coagulopathy. The levels of most coagulation proteins in premature infants change with gestational development , resulting in wide ranges of standard coagulation screening tests such as the prothrombin time (PT) and activated plasma thromboplastin time (APTT, Fig.…”
Section: Introductionmentioning
confidence: 99%
“…In many instances, FFP might be administered just to correct “prolonged” values in coagulation tests that might actually be developmentally appropriate. A large proportion of FFP transfusions in these infants cannot be easily justified based on risk or prior confirmed hemorrhage 5 , 6 …”
Section: Introductionmentioning
confidence: 99%